Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)

NCT06989957 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06989957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06989957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Recruiting
Start date
September 17, 2025
Completion date
August 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder